Access cutting-edge autoimmune hemolytic anemia treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.
Access autoimmune hemolytic anemia specialists in Minneapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related autoimmune hemolytic anemia treatment provided free
The purpose of this study is to evaluate efficacy and safety of ianalumab compared to placebo in patients with warm autoimmune hemolytic anemia, who failed at least one line of treatment.
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this autoimmune hemolytic anemia clinical trial in Minneapolis, MN
If you're searching for autoimmune hemolytic anemia treatment options in Minneapolis, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced autoimmune hemolytic anemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.